A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids

Stopped early · Not applicable

Conditions studied: Keloid

In brief

This investigator initiated study, single-blinded, parallel, randomized study will be conducted in subjects with 2 or more keloids similar in size and duration on a similar area of the body. The response of the closure techniques will be evaluated by clinical and instrumental assessments. Each qualified subject will be assessed and the keloids will be randomly assigned to the Clozex or suture closure. One keloid will be surgically excised and the surgical wound generated will be randomized to be closed with Clozex. A second keloid will be surgically excised and the surgical wound generated will be randomized to be closed with sutures. The inflammation index and the keloid recurrence rate at each surgical wound closure site will be compared.

Key facts

Study ID

NCT00519493

Run by

University of Miami

People needed

3

Starts

2007-08-01

Expected to finish

2007-12-01

Last updated by the study team

2019-03-08

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or females, in good health, and at least 12 years of age.
• Individuals with 2 or more keloids on the trunk, arm, leg, and neck between 0.5 and 2 cm in length.
• Individuals who are willing and able to participate in the requirements of the study, including signing the informed consent.
• In the opinion of the investigator, the 2 keloids can be excised in a similar manner and closed properly with the two techniques and will benefit from the procedure.
• In the opinion of the investigator, the keloid could benefit from surgical procedure.

You may not qualify if…

• Individuals with keloids that do not fit into the criteria.
• Individuals who are planning pregnancy, pregnant, or breast feeding.
• Individuals with a history of medical or dermatologic conditions which, in the opinion of the investigator, would put the subject at heightened risk or would limit complicate the study evaluations required by the protocol.
• Individuals who present with excessive body hair in the designed keloid area.
• Individuals with uncontrolled diabetes.
• Individuals with autoimmune disorders (HIV/AIDs, SLE).
• Subjects who have received keloid treatment within one month of the first day of the study.
• Individuals who plan to receive keloid treatment(s) during the study.
• Individuals who are currently taking prescription or over the counter medication or interventions on a regular basis that as part of their mechanism of action, have the potential to mask an inflammatory reaction. Examples of such medications include, but are not limited to, corticosteroids, non-steroid anti-inflammatory drugs (NSAIDs), antihistamines, aspirin (81mg or less daily dosage permissible), or other medications that in the opinion of the investigator or designee may expose the subject to heightened risk or complicate the study assessments.

Where it is running

• Skin Research Group Office — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.